Skip to content

Minimal Surgical Treatment for Obstructive Sleep Apnea (OSA)

Possible Efficacy of Minimal Surgical Treatment for Obstructive Sleep Apnea (OSA)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04367558
Enrollment
30
Registered
2020-04-29
Start date
2020-06-01
Completion date
2022-05-31
Last updated
2020-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Syndromes, Obstructive

Brief summary

Obstructive Sleep apnea carries a variety of complications and implications. While the disease could be treated using continuous positive airway pressure (CPAP) and lifestyle changes, many patients find it difficult to adjust to the mask, and turn to surgical options. The conventional surgical options to date ranges from radical (UPPP) to individualized, with or without Drug-induced sleep endoscopy (DISE). Previous studies showed that dise directed surgery can be useful for specific conditions. No trials were found to test in-office encompassing minimal invasive surgical treatment (RF palatoplasty , RF tonsillotomy, RF turbinectomy, and RF base-of-tongue reduction) as a viable alternative..

Interventions

PROCEDUREMinimally invasive, in-office, RF reduction of the affected area

Usage of RF needle to treat one or more of the affected areas

Sponsors

Hillel Yaffe Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No

Inclusion criteria

* Patients suffering from OSA, defined as AHI \> 5

Exclusion criteria

* Patients who can use CPAP. * Patients suffering from confounding factors with higher risk (Coagulation problems, Heart conditions, chronic obstructive pulmonary disease (COPD), or other dangerous conditions as decided by the surgeon) * Patients suffering from other problems aggravating the OSA (Respiratory, Neurologic conditions)

Design outcomes

Primary

MeasureTime frameDescription
More than 50% improvement in Apnea-Hypopnea index (AHI)6 months following the procedureMeasuring the AHI score using sleep laboratory
Reduction of AHI to below 206 months following the procedureMeasuring the AHI score using sleep laboratory

Countries

Israel

Contacts

Primary ContactItzhak Braverman, MD
braverman@hy.health.gov.il972-4-7744664
Backup ContactIsaac Shochat, MD
isaacs@hy.health.gov.il972-4-7744664

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026